In another attempt to enhance the natural function of tumor-infiltrating NK cells, antibody constructs known as bispecific killer engagers (BiKE) have been developed, which bring these cells into contact with tumor cells in an antigen-specific manner via CD16 [78,79,80,81,82]. This evidence concerns the gene FCGR3A and neoplasm.